RecallRadar

FDA Drug recall D-0361-2019

Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810

On 2019-01-23 the FDA classified a Class II recall of Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810 by Aurobindo Pharma Usa, citing CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily inta….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0361-2019
ClassificationClass II
Statusongoing
Initiated2018-12-31
Published2019-01-23
Last updated2026-09-13 11:52 UTC
CompanyAurobindo Pharma Usa
DistributionUS

Product

Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-737-30

Reason

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Identifiers

ndc65862-737-30
ndc65862-737-90
ndc65862-737-10
ndc65862-737-03
ndc65862-739-30
ndc65862-739-90
ndc65862-739-10
ndc65862-739-03
ndc65862-738-30
ndc65862-738-90
ndc65862-738-10
ndc65862-738-03
ndc65862-740-30
ndc65862-740-90
ndc65862-740-10
ndc65862-740-03
code_infoLot # VESA17013-A, exp. 10/2019 Lot # VESA17014-A, exp. 10/2019 Lot # VESA18001-A, exp. 12/2019 Lot # VESA18002-A, exp. 12/2019

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0361-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.